SAM
GILD icon

Storebrand Asset Management’s Gilead Sciences GILD Stock Holding History

Storebrand Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119M Sell
939,277
-12,879
-1% -$1.7M 0.29% 68
2026
Q1 		$133M Buy
952,156
+11,410
+1% +$1.6M 0.38% 51
2025
Q4 		$115M Sell
940,746
-14,740
-2% -$1.79M 0.31% 67
2025
Q3 		$106M Sell
955,486
-9,005
-0.9% -$1.02M 0.28% 72
2025
Q2 		$107M Buy
964,491
+44,447
+5% +$4.73M 0.31% 67
2025
Q1 		$103M Buy
920,044
+124,979
+16% +$12.9M 0.34% 65
2024
Q4 		$73.4M Buy
795,065
+172,061
+28% +$15.5M 0.22% 92
2024
Q3 		$52.2M Sell
623,004
-185,776
-23% -$14.2M 0.16% 138
2024
Q2 		$55.5M Sell
808,780
-29,990
-4% -$2M 0.18% 122
2024
Q1 		$61.4M Sell
838,770
-126,402
-13% -$9.72M 0.21% 112
2023
Q4 		$78.2M Sell
965,172
-28,826
-3% -$2.24M 0.28% 77
2023
Q3 		$74.5M Sell
993,998
-19,002
-2% -$1.46M 0.36% 58
2023
Q2 		$78.1M Buy
1,013,000
+6,596
+0.7% +$526K 0.36% 56
2023
Q1 		$83.5M Buy
1,006,404
+45,249
+5% +$3.75M 0.42% 51
2022
Q4 		$82.5M Sell
961,155
-15,336
-2% -$1.21M 0.46% 46
2022
Q3 		$60.2M Sell
976,491
-42,785
-4% -$2.7M 0.36% 65
2022
Q2 		$63M Buy
1,019,276
+5,567
+0.5% +$345K 0.36% 66
2022
Q1 		$60.3M Buy
1,013,709
+186,416
+23% +$11.9M 0.28% 81
2021
Q4 		$60.1M Buy
827,293
+112,314
+16% +$7.74M 0.27% 86
2021
Q3 		$49.9M Sell
714,979
-7,848
-1% -$551K 0.24% 91
2021
Q2 		$49.8M Sell
722,827
-14,035
-2% -$937K 0.24% 96
2021
Q1 		$47.6M Buy
736,862
+10,725
+1% +$692K 0.25% 86
2020
Q4 		$42.3M Buy
726,137
+54,114
+8% +$3.27M 0.25% 92
2020
Q3 		$42.5M Buy
672,023
+90,374
+16% +$6.27M 0.3% 71
2020
Q2 		$44.8M Sell
581,649
-23,070
-4% -$1.77M 0.37% 55
2020
Q1 		$45.2M Buy
+604,719
New +$41.8M 0.47% 44

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Storebrand Asset Management's GILD Position: Q2 2026 in Review

Storebrand Asset Management reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $1.7M and leaving 939,277 shares worth $119M. The position accounts for 0.29% of the portfolio, ranked #68.

Storebrand Asset Management first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. The position peaked at $133M in Q1 2026. 2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Storebrand Asset Management held 939,277 shares of Gilead Sciences worth $119M as of Q2 2026.
  • Storebrand Asset Management sold 12,879 Gilead Sciences shares in Q2 2026, an estimated $1.7M.
  • Gilead Sciences made up 0.29% of Storebrand Asset Management's portfolio in Q2 2026, its #68 holding.
  • Storebrand Asset Management first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's Gilead Sciences position peaked at $133M in Q1 2026.
  • 2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.